Literature DB >> 20220085

Toxin-coupled MHC class I tetramers can specifically ablate autoreactive CD8+ T cells and delay diabetes in nonobese diabetic mice.

Benjamin G Vincent1, Ellen F Young, Adam S Buntzman, Rosemary Stevens, Thomas B Kepler, Roland M Tisch, Jeffrey A Frelinger, Paul R Hess.   

Abstract

There is compelling evidence that self-reactive CD8(+) T cells are a major factor in development and progression of type 1 diabetes in animals and humans. Hence, great effort has been expended to define the specificity of autoimmune CD8(+) T cells and to alter their responses. Much work has focused on tolerization of T cells using proteins or peptides. A weakness in this approach is that residual autoreactive T cells may be activated and exacerbate disease. In this report, we use a novel approach, toxin-coupled MHC class I tetramers. Used for some time to identify Ag-specific cells, in this study, we use that same property to delete the Ag-specific cells. We show that saporin-coupled tetramers can delete islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP)-reactive T cells in vitro and in vivo. Sequence analysis of TCRbeta-chains of IGRP(+) cells reveals the repertoire complexity in the islets is markedly decreased as NOD mice age and significantly altered in toxic tetramer-treated NOD mice. Further tetramer(+) T cells in the islets are almost completely deleted, and, surprisingly, loss of tetramer(+) T cells in the islets is long lasting. Finally, we show deletion at 8 wk of age of IGRP(+) CD8(+) T cells, but not dystophia myotonica kinase- or insulin B-reactive cells, significantly delays diabetes in NOD mice.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20220085      PMCID: PMC2868268          DOI: 10.4049/jimmunol.0903931

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  43 in total

1.  Expansion of the antigenic repertoire of a single T cell receptor upon T cell activation.

Authors:  A Amrani; P Serra; J Yamanouchi; J D Trudeau; R Tan; J F Elliott; P Santamaria
Journal:  J Immunol       Date:  2001-07-15       Impact factor: 5.422

2.  Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus.

Authors:  Kevan C Herold; William Hagopian; Julie A Auger; Ena Poumian-Ruiz; Lesley Taylor; David Donaldson; Stephen E Gitelman; David M Harlan; Danlin Xu; Robert A Zivin; Jeffrey A Bluestone
Journal:  N Engl J Med       Date:  2002-05-30       Impact factor: 91.245

3.  Analysis of structure and function relationships of an autoantigenic peptide of insulin bound to H-2K(d) that stimulates CD8 T cells in insulin-dependent diabetes mellitus.

Authors:  F Susan Wong; Antonis K Moustakas; Li Wen; George K Papadopoulos; Charles A Janeway
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-09       Impact factor: 11.205

Review 4.  The role of CD4 vs. CD8 T cells in IDDM.

Authors:  F S Wong; C A Janeway
Journal:  J Autoimmun       Date:  1999-11       Impact factor: 7.094

5.  Elevated NF-kappaB activation in nonobese diabetic mouse dendritic cells results in enhanced APC function.

Authors:  Brian Poligone; Donald J Weaver; Pradip Sen; Albert S Baldwin; Roland Tisch
Journal:  J Immunol       Date:  2002-01-01       Impact factor: 5.422

6.  No effect of oral insulin on residual beta-cell function in recent-onset type I diabetes (the IMDIAB VII). IMDIAB Group.

Authors:  P Pozzilli; D Pitocco; N Visalli; M G Cavallo; R Buzzetti; A Crinò; S Spera; C Suraci; G Multari; M Cervoni; M L Manca Bitti; M C Matteoli; G Marietti; F Ferrazzoli; M R Cassone Faldetta; C Giordano; M Sbriglia; E Sarugeri; G Ghirlanda
Journal:  Diabetologia       Date:  2000-08       Impact factor: 10.122

7.  Islet lymphocyte subsets in male and female NOD mice are qualitatively similar but quantitatively distinct.

Authors:  Ellen F Young; Paul R Hess; Larry W Arnold; Roland Tisch; Jeffrey A Frelinger
Journal:  Autoimmunity       Date:  2009       Impact factor: 2.815

8.  Antigen-specific modulation of an immune response by in vivo administration of soluble MHC class I tetramers.

Authors:  R Maile; B Wang; W Schooler; A Meyer; E J Collins; J A Frelinger
Journal:  J Immunol       Date:  2001-10-01       Impact factor: 5.422

9.  Progression of autoimmune diabetes driven by avidity maturation of a T-cell population.

Authors:  A Amrani; J Verdaguer; P Serra; S Tafuro; R Tan; P Santamaria
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

10.  Restricted islet-cell reactive T cell repertoire of early pancreatic islet infiltrates in NOD mice.

Authors:  Felix J Baker; Mark Lee; Yueh-hsiu Chien; Mark M Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-24       Impact factor: 11.205

View more
  30 in total

1.  DEC-205-mediated antigen targeting to steady-state dendritic cells induces deletion of diabetogenic CD8⁺ T cells independently of PD-1 and PD-L1.

Authors:  Gayatri Mukherjee; Ari Geliebter; Jeffrey Babad; Pere Santamaria; David V Serreze; Gordon J Freeman; Kristin V Tarbell; Arlene Sharpe; Teresa P DiLorenzo
Journal:  Int Immunol       Date:  2013-09-10       Impact factor: 4.823

Review 2.  Viruses and cytotoxic T lymphocytes in type 1 diabetes.

Authors:  Ken T Coppieters; Matthias G von Herrath
Journal:  Clin Rev Allergy Immunol       Date:  2011-10       Impact factor: 8.667

Review 3.  Targeting regulatory T cells in cancer.

Authors:  William L Byrne; Kingston H G Mills; James A Lederer; Gerald C O'Sullivan
Journal:  Cancer Res       Date:  2011-11-08       Impact factor: 12.701

Review 4.  T-cell autoantigens in the non-obese diabetic mouse model of autoimmune diabetes.

Authors:  Jeffrey Babad; Ari Geliebter; Teresa P DiLorenzo
Journal:  Immunology       Date:  2010-10-13       Impact factor: 7.397

5.  Beyond HLA-A*0201: new HLA-transgenic nonobese diabetic mouse models of type 1 diabetes identify the insulin C-peptide as a rich source of CD8+ T cell epitopes.

Authors:  Zoltan Antal; Jason C Baker; Carla Smith; Irene Jarchum; Jeffrey Babad; Gayatri Mukherjee; Yang Yang; John Sidney; Alessandro Sette; Pere Santamaria; Teresa P DiLorenzo
Journal:  J Immunol       Date:  2012-04-25       Impact factor: 5.422

6.  An update on the use of NOD mice to study autoimmune (Type 1) diabetes.

Authors:  Rodolfo José Chaparro; Teresa P Dilorenzo
Journal:  Expert Rev Clin Immunol       Date:  2010-11       Impact factor: 4.473

7.  Inducing immune tolerance: a focus on Type 1 diabetes mellitus.

Authors:  Dan Xu; Suchitra Prasad; Stephen D Miller
Journal:  Diabetes Manag (Lond)       Date:  2013-09-01

8.  Targeting Anti-Insulin B Cell Receptors Improves Receptor Editing in Type 1 Diabetes-Prone Mice.

Authors:  Rachel H Bonami; James W Thomas
Journal:  J Immunol       Date:  2015-10-02       Impact factor: 5.422

9.  Single-Cell RNA Sequencing Reveals Expanded Clones of Islet Antigen-Reactive CD4+ T Cells in Peripheral Blood of Subjects with Type 1 Diabetes.

Authors:  Karen Cerosaletti; Fariba Barahmand-Pour-Whitman; Junbao Yang; Hannah A DeBerg; Matthew J Dufort; Sara A Murray; Elisabeth Israelsson; Cate Speake; Vivian H Gersuk; James A Eddy; Helena Reijonen; Carla J Greenbaum; William W Kwok; Erik Wambre; Martin Prlic; Raphael Gottardo; Gerald T Nepom; Peter S Linsley
Journal:  J Immunol       Date:  2017-05-31       Impact factor: 5.422

Review 10.  Cell-based interventions to halt autoimmunity in type 1 diabetes mellitus.

Authors:  A E Barcala Tabarrozzi; C N Castro; R A Dewey; M C Sogayar; L Labriola; M J Perone
Journal:  Clin Exp Immunol       Date:  2013-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.